Skip to content
10-K/A

Annual Report

Fusion Pharmaceuticals Inc.

0000950170-24-043865

← back to feed
Filed
Apr 12, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 3, 2024 84.87M sh